2022-08-12

Beijing issues latest directive: Exploring new open-development models for the development and application of stem cell, genetic diagnosis, and therapeutic technologies.

Explore new open-development models for stem cell, genetic diagnostics, and therapeutic technology development and application. Implement major initiatives such as tackling critical core technologies and enhancing clinical translation capabilities, accelerating the creation of a world-class industrial cluster.

+

2022-08-12

Henan Provincial Development and Reform Commission: Supports launching pilot reforms in areas such as cell therapy, leveraging the China (Henan) Pilot Free Trade Zone.

Henan Provincial Development and Reform Commission: We will continue to deepen international cooperation and support pilot reforms—particularly in areas such as cell therapy, traditional Chinese medicine, and regulatory oversight of TCM medical devices—leveraging the China (Henan) Pilot Free Trade Zone. Additionally, we will encourage medical institutions within the zone to import urgently needed, highly effective foreign-approved yet domestically unlisted pharmaceuticals and medical devices.

+

2022-08-03

Shenzhen's Dapeng New Area has issued a document stating that, in response to the growing demand for industries like stem cells and genetics, it will actively seek to introduce pioneering policies—similar to those already implemented in Hainan's Boao Lecheng area—within the new district.

The plan explicitly states: Actively seek pilot policies for biomedicine, aligning with the growing demand of precision medicine industries such as gene therapy and stem cells. Additionally, we will proactively work to introduce these pioneering initiatives—originally implemented in areas like Boao Lecheng in Hainan—into the new development zone.

+

2022-07-28

Up to 300 million yuan in funding available! Shenzhen Development and Reform Commission issues a notice on three policies, including the "Several Measures to Promote High-Quality Development of the Biopharmaceutical Industry Cluster in Shenzhen."

Support applying for national-level qualifications to facilitate clinical translation, promote application, and launch pilot programs for cutting-edge stem cell technologies and new products. Focus will be placed on conducting foundational research into hematopoietic stem cells, umbilical cord mesenchymal stem cells, the storage of umbilical cord mesenchymal stem cells, and pluripotent stem cells, among others.

+

2022-07-19

Chinese Super League player Sun Junhao will undergo stem cell injection treatment and is expected to return as early as the end of August.

On July 17, according to information released by Sun Junhao's agency, the player sustained a medial collateral ligament injury in his right knee during the 10th round of the Chinese Super League. While the injury isn't considered severe, Sun will now undergo stem cell injection therapy. He is expected to return to action as early as the end of August.

+

2022-07-12

Concord Medicine: The Beauty Application Prospects of Stem Cells

The safety of clinical applications of stem cells has already been preliminarily demonstrated, and we believe that in the near future, stem cell therapies will become a part of our daily lives, safeguarding people's health!

+

2022-06-28

Zhejiang issues document: Leveraging the Zhejiang Free Trade Zone to explore and advance clinical research in cutting-edge biomedical fields such as stem cell and gene therapy.

The notice states: Leveraging the China (Zhejiang) Pilot Free Trade Zone (hereinafter referred to as Zhejiang FTZ), we will explore and advance clinical research in cutting-edge biomedical fields such as immune cells, stem cells, and gene therapy.

+

2022-06-09

Shenzhen has recently issued a document: Pioneering and testing policies to promote research and translation of cutting-edge technologies such as cell and gene therapies.

The Action Plan emphasizes: Fully leveraging the legislative powers of the Special Economic Zones and their role as pilot areas for comprehensive authorization reforms, to drive the advancement of research and translation in cutting-edge technologies such as cell and gene therapies. It also calls for piloting policies that allow the conditional use of Hong Kong and Macao-registered and approved drugs, traditional Chinese medicines, and bio-based raw materials—currently not yet approved domestically—within licensed medical institutions, as well as facilitating cross-border circulation of these products.

+

2022-06-08

China's Ministry of Propaganda Holds Press Conference on "China in the Past Decade" | Minister of Science and Technology Wang Zhigang Highlights China's Breakthroughs in Fields Like Stem Cells, Marked by a Series of Internationally Recognized Original Achievements

On June 6, at the "China in the Past Decade" press conference hosted by the Publicity Department of the CPC Central Committee, China's Minister of Science and Technology, Wang Zhigang, emphasized that in tackling the world's cutting-edge scientific and technological fields, we have consistently pursued both goal-oriented approaches and free explorations. As a result, we've achieved a series of original breakthroughs with global impact in areas such as quantum information, stem cells, and brain science.

+
< 1...91011...31 >